A team of researchers and patient advocates have addressed the challenges related to traveling after receiving 177Lu-DOTATATE radiation therapy in a study published in the April issue of The Journal of Nuclear Medicine. Due ...
Apr 27, 2020
0
2
In late 2017, a 69-year-old American man who had just received a lutetium 177-based radiation treatment for his pancreatic cancer died. Five days later, his remains were cremated.
Feb 26, 2019
1
666
Federal regulators are pulling the plug on a five-year study of the risk of cancer in communities around six U.S. nuclear plants and a nuclear fuel site.
Sep 9, 2015
0
11
When environmental toxicologist Edward Calabrese in the School of Public Health and Health Sciences at the University of Massachusetts Amherst heard recently that the U.S. National Regulatory Commission has opened a new docket ...
Jul 23, 2015
0
66
A proposed study could help determine if there is a link between living near nuclear power plants or other nuclear facilities and having a higher risk of cancer, but challenges and limitations exist, says a new report from ...
Mar 29, 2012
0
0
Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments ...
May 5, 2011
0
0
